Oncology Breakthroughs: How Cancer Research Is Advancing in 2025

USA News Group Commentary
Issued on behalf of Oncolytics Biotech Inc.

VANCOUVER, BC, Feb. 27, 2025 /CNW/ -- USA News Group News Commentary – Now that World Cancer Day (Feb. 4) has come and gone, the world and the market are looking towards what's being discussed among oncology experts around the world. Recently, the New York Times put out a report asking big questions about cancer and its treatments, including about the impact of pollution (including microplastics) on cancer rates, genetic mutations, and inflammation. In the UK, The Guardian reported research showing a need for further studies into air pollution as lung cancer diagnoses are on the rise among never-smokers worldwide. As well, experts are sounding the alarm as colorectal cancer rates have skyrocketed among young people. Another report found that the EU is lagging behind the USA in oncology innovation. Among the innovators working diligently for more breakthroughs, recent developments have come from Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC.TO), Celcuity Inc. (NASDAQ:CELC), Genenta Science SPA (NASDAQ:GNTA), Sellas Life Sciences Group, Inc. (NASDAQ:SLS), and Amgen Inc. (NASDAQ:AMGN).